NCT01078675 - An Study to Evaluate Rosuvastatin in Children and Adolescents With Familial Hypercholesterolaemia | Biotech Hunter

Enrollment

315

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Familial Hypercholesterolaemia

Interventions

DRUG

rosuvastatin calcium

5 mg, oral, once daily, 24 months

DRUG

rosuvastatin calcium

10 mg, oral, once daily, 24 months

DRUG

rosuvastatin calcium

20 mg, oral, once daily, 24 months

Trial Locations (15)

Research Site, Cincinnati

Research Site, Leuven

Research Site, Vancouver

Research Site, Hamilton

Research Site, Toronto

Research Site, Chicoutimi

Research Site, Québec

Research Site, Amsterdam

Research Site, Groningen

Research Site, Hoorn

Research Site, Leiderdorp

Research Site, Rotterdam

Research Site, Waalwijk

Research Site, Oslo